Periodontitis, characterized by inflammatory loss of tooth-supporting tissues associated with biofilm, is among the most prevalent chronic diseases globally, affecting approximately 50% of the adult population to a moderate extent and cases of severe periodontitis surpassing the one billion mark. Proteomics analyses of blood, serum, and oral fluids have provided valuable insights into the complex processes occurring in the inflamed periodontium. However, until now, proteome analyses have been primarily limited to small groups of diseased versus healthy individuals. The emergence of population-scale analysis of proteomic data offers opportunities to uncover disease-associated pathways, identify potential drug targets, and discover biomarkers. In this review, we will explore the applications of proteomics in population-based studies and discuss the advancements it brings to our understanding of periodontal inflammation. Additionally, we highlight the challenges posed by currently available data and offer perspectives for future applications in periodontal research. This review aims to explain the ongoing efforts in leveraging proteomics for elucidating the complexities of periodontal diseases and paving the way for clinical strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pmic.202400055 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Population Proteomics: A Tool to Gain Insights Into the Inflamed Periodontium.
Proteomics
December 2024
Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany.
Periodontitis, characterized by inflammatory loss of tooth-supporting tissues associated with biofilm, is among the most prevalent chronic diseases globally, affecting approximately 50% of the adult population to a moderate extent and cases of severe periodontitis surpassing the one billion mark. Proteomics analyses of blood, serum, and oral fluids have provided valuable insights into the complex processes occurring in the inflamed periodontium. However, until now, proteome analyses have been primarily limited to small groups of diseased versus healthy individuals.
View Article and Find Full Text PDFGingiva as immunological protection of the periodontium. Minireview.
Neuro Endocrinol Lett
November 2024
Private Dental Practice, Krížna 44, Bratislava, Slovakia.
Objectives: The anti-infective, predominantly antibacterial protection of the periodontium has been well-mapped in its various inflammatory diseases, especially in different clinical forms of gingivitis and periodontitis. In various inflammatory periodontal diseases, many immunocompetent cells and substances have been identified in periodontal structures, including the gingiva, which implement and ensure this anti-inflammatory response. There is ample evidence that in many clinical forms of gingivitis and periodontitis, these immunological-defensive reactions occur in the gingival tissue.
View Article and Find Full Text PDFLocal Controlled Delivery of IL-4 Decreases Inflammatory Bone Loss in a Murine Model of Periodontal Disease.
J Immunol
December 2024
Center for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.
Chronic inflammatory diseases are a leading global health problem. In many of these diseases, the consistent presence of systemic low-grade inflammation induces tissue damage. This is true in conditions such as diabetes, arthritis, and autoimmune disorders, where an overactive and uncontrolled host immune response is a major driver of immunopathology.
View Article and Find Full Text PDFMimicking and in vitro validating chronic inflammation in human gingival fibroblasts.
Arch Oral Biol
January 2025
Department of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway; FUTURE, Center for Functional Tissue Reconstruction, University of Oslo, Oslo, Norway. Electronic address:
Article Synopsis
- The study aimed to replicate inflammatory conditions of human gingiva by using human gingiva fibroblast cells cultured under specific serum starvation conditions with various concentrations of lipopolysaccharides and interleukin 1β.
- Results showed that while P. gingivalis LPS did not increase inflammation markers, E. coli LPS and IL-1β did enhance the secretion of pro-inflammatory cytokines like IL-6 and TNFα, particularly when used together.
- The combination treatment mimicked gene expression changes and cytokine profiles observed in chronic inflammation, suggesting it could serve as a useful model for studying gingival inflammation in vitro.
Acceleration of HDL-Mediated Cholesterol Efflux Alleviates Periodontitis.
J Dent Res
October 2024
Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea.
Periodontitis (PD) is a common inflammatory disease known to be closely associated with metabolic disorders, particularly hyperlipidemia. In the current study, we demonstrated that hypercholesterolemia is a predisposing factor in the development of PD. Logistic regression analysis revealed a strong positive correlation between PD and dyslipidemia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!